胸腔注入尿激酶治疗结核性胸膜炎疗效观察

目的：探讨胸腔穿刺手术时胸腔内注射尿激酶治疗结核性胸膜炎胸膜肥厚、粘连的临床疗效.方法：将30例结核性胸膜炎包裹性胸腔积液、胸膜肥厚、粘连患者分为两组：治疗组15例,采用胸腔穿刺术抽胸水后胸腔注射尿激酶;对照组15例,采用常规胸腔穿刺抽胸水,胸腔内不注射尿激酶.比较两组患者治疗后胸膜肥厚、粘连程度.结果：治疗组胸膜肥厚、粘连程度明显减轻,与对照组差异有统计学意义（P〈0.05）.结论：胸腔内注射尿激酶治疗结核性胸膜炎胸膜肥厚、粘连疗效肯定,操作简便,值得推广.

Chest cavity pours into urokinase treatment tubercular pleurisy curative effect observation

Objective：Discusses when the chest cavity puncture surgery in the chest cavity injects the urokinase treatment tubercular pleurisy pleu- ral membrane plump,the adhesion clinical curative effect. Methods：Wraps 30 example tubercular pleurisy the chest cavity to accumulate plump the fluid, the pleural membrane, the adhesion patient divides into two groups：The treatment group 15 examples, after use the chest cavity puncture method to pull out the chest water the chest cavity injection urokinase;The control group 15 examples,use the conventional chest cavity puncture to pull out the chest water,in the chest cavity do not inject the urokinase. Treats the pleural membrane after two group of patients plump, the adhesion degree. Results：Treats the group pleural membrane plump, the adhesion degree reduces obviously, has statistics significance with the control group difference （P〈0.05）. Conclusion：In the chest cavity injects the urokinase treatment tubercular pleurisy pleural membrane plump, the adhesion curative effect affirmed that,the operation is simple,is worth promoting.